After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Summit Therapeutics Inc is $15.05B. A total of 3.03 million shares were traded on the day, compared to an average of 4.09M shares.
In the most recent transaction, Zanganeh Mahkam bought 333,394 shares of SMMT for 17.68 per share on Sep 10 ’25. After the transaction, the Co-Chief Executive Officer now owns 556,088,090 company shares. In a previous transaction on Sep 11 ’25, Zanganeh Mahkam bought 5,000 shares at 18.07 per share. SMMT shares that Co-Chief Executive Officer owns now total 556,093,090.
Among the insiders who bought shares, DUGGAN ROBERT W acquired of 333,394 shares on Sep 10 ’25 at a per-share price of $17.68. This resulted in the Co-Chief Executive Officer holding 556,088,090 shares of SMMT after the transaction. In another insider transaction, DUGGAN ROBERT W bought 5,000 shares at $18.07 per share on Sep 11 ’25. Company shares held by the Co-Chief Executive Officer now total 556,093,090.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, SMMT has a high of $36.91 and a low of $15.55.
As of this writing, SMMT has an earnings estimate of -$0.04 per share for the current quarter. EPS was calculated based on a consensus of 11.0 estimates, with a high estimate of $0.85 per share and a lower estimate of -$0.55. The company reported an EPS of -$0.06 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. SMMT’s latest balance sheet shows that the firm has $71.79M in Cash & Short Term Investments as of fiscal 2021. There were $2.78M in debt and $25.62M in liabilities at the time. Its Book Value Per Share was $0.35, while its Total Shareholder’s Equity was $83.28M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SMMT is Buy with a score of 4.13.
